Composite Adenomatoid Tumor with Myelolipoma of Adrenal Gland: Case Report
(2025). Composite Adenomatoid Tumor with Myelolipoma of Adrenal Gland: Case Report. EKB Journal Management System, 5(2), -. doi: 10.21608/esdlj.2025.456305
. "Composite Adenomatoid Tumor with Myelolipoma of Adrenal Gland: Case Report". EKB Journal Management System, 5, 2, 2025, -. doi: 10.21608/esdlj.2025.456305
(2025). 'Composite Adenomatoid Tumor with Myelolipoma of Adrenal Gland: Case Report', EKB Journal Management System, 5(2), pp. -. doi: 10.21608/esdlj.2025.456305
Composite Adenomatoid Tumor with Myelolipoma of Adrenal Gland: Case Report. EKB Journal Management System, 2025; 5(2): -. doi: 10.21608/esdlj.2025.456305

Composite Adenomatoid Tumor with Myelolipoma of Adrenal Gland: Case Report

Egyptian Society of Diabetes and Lipidology Journal
Volume 5, Issue 2, October 2025    PDF (907.33 K)
Document Type: Case Report
DOI: 10.21608/esdlj.2025.456305
Abstract
Adenomatoid tumor (AT) and myelolipoma are benign, hormonally inactive neoplasms of mesothelial origin, usually occurring in the male and female genital tracts. Rare extragenital adenomatoid tumors have been identified in the adrenal glands, heart, mesentery, pleura, and lymph nodes. Those are often incidental findings in the adrenal glands. Myelolipoma is more common than adenomatoid tumor in this location but both are rare, yet the pathogenesis of both remains unclear 
Statistics
Article View: 32
PDF Download: 13